NASDAQ:RMTI Rockwell Medical (RMTI) Stock Price, News & Analysis $1.89 +0.04 (+2.16%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$1.82▼$1.9750-Day Range$1.67▼$2.1552-Week Range$1.16▼$3.72Volume82,920 shsAverage Volume147,883 shsMarket Capitalization$57.30 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Rockwell Medical alerts: Email Address Rockwell Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside270.4% Upside$7.00 Price TargetShort InterestHealthy2.01% of Float Sold ShortDividend StrengthN/ASustainability-2.35Upright™ Environmental ScoreNews Sentiment0.94Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.14) to $0.04 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.42 out of 5 starsMedical Sector129th out of 936 stocksPharmaceutical Preparations Industry49th out of 436 stocks 3.5 Analyst's Opinion Consensus RatingRockwell Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageRockwell Medical has only been the subject of 1 research reports in the past 90 days.Read more about Rockwell Medical's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.01% of the float of Rockwell Medical has been sold short.Short Interest Ratio / Days to CoverRockwell Medical has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rockwell Medical has recently decreased by 19.36%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldRockwell Medical does not currently pay a dividend.Dividend GrowthRockwell Medical does not have a long track record of dividend growth. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRockwell Medical has received a 58.29% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Iron deficiency medication" and "Clinical research services for deficiency diseases" products. See details.Environmental SustainabilityThe Environmental Impact score for Rockwell Medical is -2.35. Previous Next 3.9 News and Social Media Coverage News SentimentRockwell Medical has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Rockwell Medical this week, compared to 1 article on an average week.Search Interest3 people have searched for RMTI on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat Follows3 people have added Rockwell Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rockwell Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.90% of the stock of Rockwell Medical is held by insiders.Percentage Held by InstitutionsOnly 23.31% of the stock of Rockwell Medical is held by institutions.Read more about Rockwell Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Rockwell Medical are expected to grow in the coming year, from ($0.14) to $0.04 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rockwell Medical is -5.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rockwell Medical is -5.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRockwell Medical has a P/B Ratio of 2.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Rockwell Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Rockwell Medical Stock (NASDAQ:RMTI)Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.Read More RMTI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RMTI Stock News HeadlinesJuly 24 at 6:04 AM | americanbankingnews.comRockwell Medical (NASDAQ:RMTI) Stock Price Crosses Above 200-Day Moving Average of $1.61July 21, 2024 | seekingalpha.comRockwell Medical Looks Like A Speculative Buy As It Approaches ProfitabilityJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 9, 2024 | 247wallst.com3 Penny Stocks With 735% Average Upside, According to Wall StreetMay 30, 2024 | businesswire.comRockwell Medical Promotes Tim Chole to Chief Commercial OfficerMay 16, 2024 | markets.businessinsider.comRockwell Medical: Strong Financial Performance and Strategic Partnerships Justify Buy RatingMay 15, 2024 | msn.comRockwell Medical, Inc. (NASDAQ:RMTI) Q1 2024 Earnings Call TranscriptMay 15, 2024 | finance.yahoo.comRockwell Medical Inc (RMTI) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...July 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 15, 2024 | finance.yahoo.comQ1 2024 Rockwell Medical Inc Earnings CallMay 14, 2024 | markets.businessinsider.comRockwell Medical is about to announce its earnings — here's what to expectMay 14, 2024 | investorplace.comRMTI Stock Earnings: Rockwell Medical Beats EPS, Beats Revenue for Q1 2024May 14, 2024 | msn.comRockwell Medical Non-GAAP EPS of -$0.02, revenue of $22.7M beats by $1MMay 14, 2024 | businesswire.comRockwell Medical Announces First Quarter 2024 Results, Raises 2024 GuidanceMay 13, 2024 | msn.comRockwell Medical Q1 Earnings PreviewApril 21, 2024 | finance.yahoo.comRockwell Medical, Inc. (RMTI)April 17, 2024 | finance.yahoo.comRockwell Medical Continues to Expand its Distribution Capabilities in Western United StatesApril 16, 2024 | businesswire.comRockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024See More Headlines Receive RMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/27/2024Next Earnings (Confirmed)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:RMTI CUSIP77437410 CIK1041024 Webwww.rockwellmed.com Phone(248) 432-1362Fax248-960-9119Employees300Year Founded1995Price Target and Rating Average Stock Price Target$7.00 High Stock Price Target$9.00 Low Stock Price Target$5.00 Potential Upside/Downside+270.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.36) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,440,000.00 Net Margins-9.72% Pretax Margin-9.72% Return on Equity-28.29% Return on Assets-10.67% Debt Debt-to-Equity Ratio0.47 Current Ratio1.79 Quick Ratio1.38 Sales & Book Value Annual Sales$83.61 million Price / Sales0.69 Cash Flow$0.02 per share Price / Cash Flow97.63 Book Value$0.75 per share Price / Book2.52Miscellaneous Outstanding Shares30,320,000Free Float29,740,000Market Cap$57.30 million OptionableOptionable Beta1.43 Social Links 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Mark Strobeck Ph.D. (Age 53)President, CEO & Director Comp: $904.66kMr. Jesse Neri (Age 46)Senior Vice President of Finance Comp: $359.63kMs. Megan C. Timmins (Age 51)Executive VP, Chief Legal Officer & Secretary Comp: $585.74kMr. James A. McCarthySenior Vice President of Business & Corporate DevelopmentMr. Timothy T. CholeSenior Vice President of Sales & MarketingMs. Heather R. HunterSenior VP & Chief Corporate Affairs OfficerMr. Jason FinkelsteinInvestor Relations RepresentativeMore ExecutivesKey CompetitorselectroCoreNASDAQ:ECORIRIDEXNASDAQ:IRIXFONARNASDAQ:FONREdap TmsNASDAQ:EDAPAccurayNASDAQ:ARAYView All CompetitorsInstitutional OwnershipVanguard Group Inc.Bought 43,302 shares on 5/10/2024Ownership: 3.808%Richmond Brothers Inc.Sold 90,182 shares on 5/10/2024Ownership: 1.097%SkyOak Wealth LLCBought 8,065 shares on 4/30/2024Ownership: 0.086%View All Institutional Transactions RMTI Stock Analysis - Frequently Asked Questions How have RMTI shares performed this year? Rockwell Medical's stock was trading at $1.89 at the beginning of 2024. Since then, RMTI stock has increased by 0.0% and is now trading at $1.89. View the best growth stocks for 2024 here. How were Rockwell Medical's earnings last quarter? Rockwell Medical, Inc. (NASDAQ:RMTI) issued its quarterly earnings results on Tuesday, May, 14th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.05) by $0.03. The company earned $22.68 million during the quarter, compared to analyst estimates of $21.18 million. Rockwell Medical had a negative net margin of 9.72% and a negative trailing twelve-month return on equity of 28.29%. When did Rockwell Medical's stock split? Shares of Rockwell Medical reverse split before market open on Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split. What is Robert L. Chioini's approval rating as Rockwell Medical's CEO? 6 employees have rated Rockwell Medical Chief Executive Officer Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among the company's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. How do I buy shares of Rockwell Medical? Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Rockwell Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN) and Gilead Sciences (GILD). This page (NASDAQ:RMTI) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rockwell Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
